ArticleFrontiers in oncology2025
Case Report: Gastric and duodenal metastasis of malignant melanoma: a rare clinical presentation.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Amelanotic Gastric Metastases From Melanoma Presenting as Gastrointestinal Bleeding Shortly After Diagnosis: A Case Report.Journal of investigative medicine high impact case reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malignant melanoma represents one of the most common sources of metastatic tumors to the gastrointestinal (GI) tract. However, synchronous involvement of both the stomach and duodenum is exceptionally rare. Ante-mortem diagnosis remains challenging due to frequent asymptomatic or non-specific presentations. Endoscopically, metastases may present as ulcerated nodules, submucosal masses, or pigmented lesions, necessitating confirmation via immunohistochemical staining. Objective: This case report describes a rare instance of synchronous gastric and duodenal metastases from malignant melanoma, aiming to enhance clinical awareness of this condition. Methods: We present the case of a 67-year-old male with a history of wild-type BRAF V600E malignant melanoma of the left lower limb, status post resection three years prior, who presented for observation with known multi-system metastases. The patient reported decreased appetite but denied other GI symptoms. Upper gastrointestinal endoscopy was performed, revealing suspicious lesions in the stomach and duodenum, which were subsequently biopsied for histopathological and immunohistochemical analysis. Results: Endoscopy identified a mass on the posterior wall of the gastric fundus and the greater curvature of the upper stomach, alongside four masses in the duodenal bulb. All lesions exhibited surface melanin deposition. Histological examination revealed tumor cells with prominent nucleoli and visible melanin granules. Immunohistochemistry was positive for S100, Melan-A, and SOX10, with a high Ki67 proliferation index of 90%, confirming the diagnosis of metastatic malignant melanoma. Conclusion: This case underscores the potential for malignant melanoma to develop synchronous metastases in both the stomach and duodenum, even in the absence of specific GI symptoms (3, 6). It highlights the critical role of endoscopic evaluation and immunohistochemical analysis in achieving a timely diagnosis (4, 7). A high index of suspicion is warranted in patients with a history of melanoma, as GI metastases confer a poor prognosis (4, 7).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.